Cost analysis of home parenteral rutrition in Spain
Por:
Burgos Pelaez, R, Virgili Casas, M, Cuerda Compes, M, Moreno Villares, J, Olveira, G, Luengo Perez, L, Wanden-Berghe Lozano, C, Munoz Cuadrado, A, Torres Gonzalez, C and Casado Gomez, M
Publicada:
1 mar 2017
Resumen:
Introduction: Home parenteral nutrition (HPN) improves quality of life,
allowing patients to receive nutrition at home and providing a social
and labor integration to these patients.
Objective: To assess the direct costs of HPN in adult population in
Spain.
Methods: A literature review of the records of HPN in Spain, carry out
by NADYA-SENPE Group (years 2007-2014), was performed. The analysis
included the evolution of: patients requiring HPN, number of
episodes/patient, mean duration of episodes, description of delivery
routes and complications rate. HPN consumption and cost were estimated.
Patients were grouped according to their pathological group: benign and
malignant. Direct costs ((sic),2015) included were: parenteral nutrition
bags, delivery sets and costs due to complications.
Results: The number of patients who receive HPN has increased over years
(2007: 133 patients; 2014: 220 patients). The average number of episodes
per patient ranged from 1-2 episodes per year. The average duration of
those episodes decreased (2007: 323 days; 2014: 202.8 days). Tunneled
catheters were the most used and septic complications were the most
common. The average annual cost per patient was estimated at
(sic)8,393.30 and (sic)9,261.60 for benign and malign disease
respectively. Considering that 220 patients required HPN in 2014, an
annual cost of (sic)1,846.524.96 ((sic)1,389,910.55 directly due to HPN)
and (sic)2,037,551.90 ((sic)1,580,937.50 directly due to HPN) was
estimated for patients with benign and malignant pathologies
respectively.
Conclusions: These results can be used to develop future economic
evaluations on HPN and to establish efficient prioritization strategies
to allocate available resources.
Filiaciones:
Burgos Pelaez, R:
Hosp Valle De Hebron, Barcelona, Spain
Virgili Casas, M:
Hosp Univ Bellvitge, Barcelona, Spain
Cuerda Compes, M:
Hosp Gen Univ Gregorio Maranon, Madrid, Spain
Moreno Villares, J:
Hosp Univ 12 Octubre, Madrid, Spain
Olveira, G:
Univ Malaga, Inst Invest Biomed Malaga, Hosp Reg Malaga, Malaga, Spain
Luengo Perez, L:
Hosp Infanta Cristina, Badajoz, Spain
:
Hosp Gen Alicante, Alicante, Spain
Munoz Cuadrado, A:
Pharmacoecon & Outcomes Res Iberia PORIB, P Joaquin Rodrigo 4-1, Madrid 28224, Spain
Torres Gonzalez, C:
Pharmacoecon & Outcomes Res Iberia PORIB, P Joaquin Rodrigo 4-1, Madrid 28224, Spain
Casado Gomez, M:
Pharmacoecon & Outcomes Res Iberia PORIB, P Joaquin Rodrigo 4-1, Madrid 28224, Spain
|